22
Participants
Start Date
April 30, 2009
Primary Completion Date
December 31, 2009
Study Completion Date
October 31, 2012
axitinib
Twice daily oral dose of axitinib continuously depending upon side effects observed. Starting dose is 5mg twice daily. Each 21 day cycle is repeated until progression of disease or unacceptable toxicity is observed.
capecitabine
Given orally twice daily for 14 days followed by 7 days of drug free period. Starting dose is 1000mg/m\^2 twice daily. Each 21 day cycle is repeated until progression of disease or unacceptable toxicity is observed.
cisplatin
Given through a vein on Day 1 of every 21 days. Each 21 day cycle is repeated until progression of disease or unacceptable toxicity is observed. The starting dose is 80 mg/m\^2 on day 1.
Pfizer Investigational Site, Kashiwa
Pfizer Investigational Site, Yufu
Pfizer Investigational Site, Goyang-si
Pfizer Investigational Site, Seongnam-si
Pfizer Investigational Site, Seoul
Lead Sponsor
Pfizer
INDUSTRY